IGF-1

What Is IGF-1

Insulin-like Growth Factor 1 is a peptide hormone, structurally related to insulin, produced mostly by the liver in response to growth hormone released from the pituitary. Because circulating IGF-1 tracks growth hormone output so closely, it is commonly used as a lab biomarker, a blood IGF-1 measurement is often a practical stand-in for growth hormone activity, since GH itself is secreted in short pulses that are hard to measure directly.^[1]

Crossing The Blood-Brain Barrier

Unlike NGF, which is too large to cross the blood-brain barrier at all, circulating IGF-1 does cross, transported through a saturable system, meaning increasing peripheral IGF-1 raises brain IGF-1 correspondingly, up to the point where the transport mechanism itself becomes the limiting factor.^[1] The entry mechanism is more interesting than a simple passive gradient, neuronal activity itself triggers local uptake, active brain regions release diffusible signaling molecules that activate an enzyme which frees IGF-1 from its carrier protein, allowing it to cross into that specific, actively firing region preferentially.^[2]

What It Does For Cognition

IGF-1 is essential for adult neurogenesis, and it also facilitates synaptic communication and cognition by acting directly on ion channels and neurotransmitter systems, in addition to its trophic, growth-supporting effects.^[3] Beyond direct neuronal effects, IGF-1 supports the broader neurovascular unit, the neurons, astrocytes, and blood vessels that function together, and reduced circulating IGF-1 is associated with impaired blood-brain barrier integrity and increased microhemorrhage in animal models, meaning some of its cognitive benefit likely runs through vascular and structural brain health rather than neurons alone.^[4]

What Goes Wrong

Serum IGF-1 reliably declines with age, and this decline is one proposed contributor to age-related cognitive decline, making IGF-1 a candidate biomarker for tracking cognitive aging.^[1] Separately, metabolic syndrome, hyperglycemia, abdominal obesity, and insulin resistance are linked to disrupted IGF-1 signaling in the brain, with downstream increases in amyloid, tau, and alpha-synuclein deposition implicated in neurodegenerative disease risk.^[5]

Lifestyle Inputs

Physical activity and aerobic exercise reliably raise circulating IGF-1 in older adults, and this exercise-driven increase is proposed to improve cognition and hippocampal volume specifically by stimulating hippocampal neurogenesis, connecting directly to the exercise content covered in the Lifestyle Inputs section of this hub.^[1]

Pharmacological Inputs

Frontier Research

One active engineering problem is improving brain delivery precision for IGF-1-targeted therapies without relying on peripheral GH axis elevation at all. Researchers have developed antibody fragments that bind the IGF-1 receptor specifically at the blood-brain barrier and trigger transport across it, a strategy aimed at shuttling therapeutic cargo into the brain using the same transport machinery IGF-1 itself uses, without needing to raise systemic IGF-1 or growth hormone levels.^[9] This general approach, using the same activity-dependent, receptor-mediated transport system IGF-1 relies on naturally, is a promising direction precisely because it could decouple the cognitive benefit from the systemic cancer-risk tradeoff described above.

Practical Takeaway

IGF-1 is genuinely important for adult neurogenesis, synaptic function, and neurovascular health, and it is one of the few growth factors covered in this hub that actually crosses the blood-brain barrier from circulation, through an elegant activity-dependent transport mechanism. The honest complication is that its pro-growth, anti-apoptotic mechanism is a double-edged sword, the same properties tied to its cognitive benefits are tied to cancer risk at sustained elevated levels, and the best human evidence for that tradeoff comes from genetic deficiency studies at one extreme rather than controlled human trials at the other. Exercise remains the best supported, lowest-risk way to raise IGF-1 naturally, compared to sustained pharmacological elevation for cognitive purposes alone.

Learn Next

To go deeper here, the concepts worth studying next are the growth hormone releasing hormone and ghrelin receptor pathways and how GHRH analogs and ghrelin mimetics produce a synergistic combined pulse, the JAK-STAT signaling cascade through which the GH receptor produces its downstream effects, the specific role of IGF binding proteins, especially IGFBP-3, in regulating how much free IGF-1 is actually available to signal, and the broader concept of pro-mitotic, anti-apoptotic signaling as a recurring double-edged mechanism across growth factors, since this same tradeoff pattern is relevant well beyond IGF-1 specifically.